"Bright Green Pharmaceuticals, Inc., a Delaware company, which is the Group's pharma, medical and marketing arm, will use the product in its novel, cannabinoid-based prescription and non-prescription pharmaceutical and nutraceutical product lines"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.